{"schema_version":"secwatch.filing_event.v1","accession":"0001090872-25-000010","form_type":"8-K","ticker":"A","cik":"0001090872","company_name":"AGILENT TECHNOLOGIES, INC.","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.906437+00:00","generated_at":"2026-05-25T16:51:57.482654+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"medium","headline":"Agilent reorganizes segments into Life Sciences & Diagnostics Markets, Agilent CrossLab, Applied Markets","bullets":["Former Diagnostics & Genomics merged with LC/MS platforms into Life Sciences and Diagnostics Markets segment.","Chemistries, supplies, lab automation, software, informatics moved to Agilent CrossLab segment.","GC/MS, spectroscopy, vacuum divisions form new Applied Markets segment.","Recast of 2024 10-K Items 1, 2, 7, 8 reflects new segments; no change to audited financials."],"urls":{"canonical":"https://secwatch.observer/filing/0001090872-25-000010","json":"https://secwatch.observer/filing/0001090872-25-000010.json","markdown":"https://secwatch.observer/filing/0001090872-25-000010.md","text":"https://secwatch.observer/filing/0001090872-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1090872/000109087225000010/0001090872-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1090872/000109087225000010/a-20250303_d2.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T16:51:57.482654+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}